wire - news in brief


Results 251 - 300 of 417.

Pharmacology - Health - 17.08.2020
FDA Approves Roche’s ENSPRYNG for Neuromyelitis Optica Spectrum Disorder (NMOSD)
First and only FDA-approved subcutaneous treatment option for anti-aquaporin-4 antibody positive NMOSD that can be self-administered by a person with NMOSD or a caregiver every four weeks First and o

Physics - Life Sciences - 14.08.2020

Health - Life Sciences - 13.08.2020
IOR takes part in innovative project for real-time Covid-19 testing device
SARS-CoV-2 virus analysis involves complex procedures and requires long waiting times.

Environment - Chemistry - 11.08.2020
Florian Breider: a passion for all things Japanese
Florian Breider: a passion for all things Japanese
Summer series: Careers in research. Florian Breider, who heads EPFL's Central Environmental Laboratory (CEL), knew from a young age that he wanted to become a scientist.

Pharmacology - Health - 11.08.2020

Computer Science - Life Sciences - 11.08.2020
Blackrock Microsystems Licenses Wyss Center's Real-time Neural Signal Processing Platform
Blackrock Microsystems Licenses Wyss Center’s Real-time Neural Signal Processing Platform
The software platform, NeuroKey, interfaces with multiple brain signal acquisition sources and devices, extending the reach of brain-computer interface applications GENEVA, SWITZERLAND & SALT LAKE CITY, UTAH, USA - The Wyss Center for Bio and Neuroengineering has granted a worldwide license to Blackrock Microsystems to commercialize its neural signal processing and decoding software platform for research and clinical applications.

Life Sciences - Health - 11.08.2020
Wyss Center and Osypka announce collaboration
Wyss Center and Osypka announce collaboration
Pushing the boundaries of implantable neuro-device development Today the Wyss Center for Bio and Neuroengineering, Geneva, Switzerland and OSYPKA AG/OSYPKA Medtec, Rheinfelden, Germany and Longmont,

Pharmacology - Health - 10.08.2020
FDA approves Roche’s Evrysdi (risdiplam) for treatment of spinal muscular atrophy (SMA) in adults and children 2 months and older
In two clinical trials, Evrysdi improved motor function in people living with SMA over a broad spectrum of ages and levels of disease severity, including Types 1, 2, and 3 SMA Evrysdi helped infants

Health - 06.08.2020
Preventive Measures against Heat Contribute to Health Protection
Preventive Measures against Heat Contribute to Health Protection
On behalf of the Federal Office of Public Health, the Swiss Tropical and Public Health Institute (Swiss TPH) analysed the health consequences of the hot and dry summer of 2019 and compared it to the hot summers of 2003, 2015 and 2018. The results were published this week in the report "Health effects of heat in Switzerland and the importance of prevention measures".

Pharmacology - Health - 05.08.2020
Novartis announces NEJM publication of Phase III ASCLEPIOS trials demonstrating superior efficacy of ofatumumab in patients with relapsing multiple sclerosis
Ofatumumab is a targeted B-cell therapy that delivers superior efficacy with a similar safety profile when compared with teriflunomide, a commonly prescribed oral treatment for multiple sclerosis 1  

History / Archeology - Art and Design - 04.08.2020

Pharmacology - Health - 04.08.2020
Novartis announces Kymriah meets primary endpoint at interim analysis of pivotal study in follicular lymphoma
Global ELARA trial demonstrated clinically meaningful benefit in patients with relapsed or refractory (r/r) follicular lymphoma (FL) as measured by complete response rate   Kymriah previously receive

Social Sciences - 04.08.2020

Pharmacology - Health - 03.08.2020
Novartis Cosentyx receives EU approval for first-line systemic treatment in pediatric psoriasis
EU approval is based on two Phase III studies showing Cosentyx provides fast and strong skin clearance, along with significant improvement in quality of life and a favorable safety profile 1   Modera

Mechanical Engineering - 30.07.2020

Health - Pharmacology - 29.07.2020
Novartis receives Piqray approval in Europe - the first and only targeted medicine for HR+/HER2- advanced breast cancer with a PIK3CA mutation
Piqray (alpelisib) is the only treatment approved specifically to address PIK3CA mutation, underscoring Novartis commitment to reimagining cancer care   Approval based on SOLAR-1 Phase III trial showing Piqray plus fulvestrant nearly doubled median PFS (11.0 vs.

Computer Science - Transport - 29.07.2020
Predicting the unknown
Predicting the unknown
Olga Fink develops artificial intelligence algorithms for industrial assets, rolling stock and power plants.

Health - Life Sciences - 28.07.2020
Immunoprotein impairs Sars-Cov-2
An international team with researchers of the Institute of Virology and Immunology (IVI) of the University of Bern and the Swiss Federal Food Safety and Veterinary Office (FSVO) showed that an endogenous protein prevents the virus from fusing with host cells.

Environment - Earth Sciences - 28.07.2020
Thallium: highly toxic, but little studied
Thallium: highly toxic, but little studied
In Agatha Christie's novel The Pale Horse, the victims die of thallium poisoning.

Earth Sciences - 28.07.2020
Maartje Bastings, a scientist reaching for new heights
Maartje Bastings, a scientist reaching for new heights
Summer series - A calling for research.

Health - Computer Science - 27.07.2020
CHF 12 million funding for cutting-edge surgical technology
CHF 12 million funding for cutting-edge surgical technology
Researchers at the University of Basel have a vision: an individually configurable robot will revolutionize surgical procedures and provide numerous benefits for patients.

Pharmacology - Health - 27.07.2020
New Novartis analysis shows wet AMD patients achieved sustained fluid control faster with Beovu versus aflibercept
A post-hoc analysis of the HAWK and HARRIER trials presented at ASRS showed >=50% of patients achieved sustained retinal dryness by weeks 8 and 4 with Beovu and by weeks 12 and 8 with aflibercept,

Astronomy / Space Science - Environment - 24.07.2020

Health - Life Sciences - 22.07.2020

Research Management - 21.07.2020
Quatorze projets de collaboration HES⁠-⁠SO - Instituts polytechniques
Quatorze projets de collaboration HES⁠-⁠SO - Instituts polytechniques
HES⁠-⁠SO en bref HES-SO Actualités HES⁠-⁠SO Quatorze projets de collaboration HES⁠-⁠SO - Instituts polytechniques portugais L'appel à projets d'impulsion lancé dan

Agronomy / Food Science - 21.07.2020
"Ticino a te", bringing local produce closer to you also thanks to USI
The Osservatorio dello sviluppo territoriale (OST) (Observatory of Territorial Development), based at USI Academy of Architecture, has developed, in collaboration with Centro di Competenze Agroalimen

Architecture - History / Archeology - 21.07.2020

Economics / Business - 21.07.2020
An academic career in Finance, from Lugano to Lisbona
Lugano, St. Gallen, Barcelona, Lugano, New York, Lugano, Lisbon... these are the steps along the  academic career path of Virginia Gianinazzi, who has recently obtained her PhD in finance at U